Omega-loop gastric bypass evaluated by French HAS

08

Nov 2019

In September 2019, the French High Authority for Health (HAS) released an assessment report for gastric bypass, also known as omega loop in severe obesity. The evaluation aimed to compare omega-loop gastric bypass (OLGB) with Roux-en-Y Gastric Bypass (RYGB) in terms of efficacy and safety.

The following conclusions were provided by HAS:

  • OLGB cannot be determined as an alternative treatment to RYGB considering the safety aspects
  • There is a lack of efficacy and safety data for the OLGB with a biliopancreatic loop of 150 cm. The method should be studied in a framework of clinical research as follows:
    • Efficacy evaluation should be based on several criteria including the long-term weight loss (five years), the resolution of co-morbidities and the quality of life measured by validated scores
    • The safety assessment should include a five-year fiberoptic examination considering the risk of lower esophageal cancer
  • The outcomes of the patients who underwent OLGB should be similar to those after RYGB with specific attention to nutritional complications (protein-energy malnutrition, micronutrient deficiency) and lower esophageal cancer with fibroscopy examination at five years after the procedure

See the full health technology assessment report in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

13

Jan 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2022. Nine recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern the device used for neuromodulation, the device for the treatment of benign prostatic hyperplasia, orthopedic devices, as well as medical aids.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more

10

Jan 2023

On December 17, 2022, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the transitional coverage for the renal denervation catheter SYMPLICITY SPYRAL.

Read more